Back to Overview

A Raspberry 502700 A 501091

Raspberry Flavour

BSE / TSE

INCI/Chemical Name:: Raspberry Flavour
SKU:: BP131703

Download data

Didn't find the right document?

Available packs

To find out more about product availability,

*Minimum order quantities and price breaks may apply. Click the button below to view more details.

Request a quote

Request a sample

Raspberry Flavour 501099 A is a liquid flavour with a floral, jammy and sweet raspberry notes. Suitable for use as a flavouring excipient in oral liquid pharmaceutical products.

Would you like to know more?

Please sign in or request access to get access to the full content. In case you have any questions, please click the "Request information" button below.

New customer?

Request information

Discover our most recent inspiration articles

Product News

Multiform CSF® Desiccant Canisters: Supporting More Sustainable Moisture Protection for Pharmaceutical Packaging

Multiform CSF® desiccant canisters support sustainable, reliable pharmaceutical moisture protection.

1 day ago

5 min read

Azelis News Knowledge

From crisis to delivery: real situations where the Azelis supply chain made the difference

Real supply chain crises managed by Azelis

10 days ago

5 min read

Azelis News Knowledge

When disruption hits: how the Azelis supply chain team responds

How Azelis protects supply when disruption hits

17 days ago

5 min read

Market Trends Product News

AEROSIL® Pharma, the reference glidants: from classic tableting to continuous manufacturing

AEROSIL® Pharma improves powder flow for reliable solid dosage manufacturing.

22 days ago

7 min read

Azelis News Knowledge

Built for flexibility: the Azelis supply chain network across EMEA

A flexible EMEA network protecting customer supply

24 days ago

5 min read

Product News

Pharmacel® 200 - Advanced MCC Grade for Robust Formulation and Process Reliability

Discover Pharmacel® 200, DFE Pharma’s advanced microcrystalline cellulose (MCC) grade, delivering superior powder flow, process reliability, batch-to-batch consistency, and support for nitrosamine risk mitigation in pharmaceutical formulations.

1 month ago

7 min read

See all articles